Barnes_1993_Agents.Actions.Suppl_43_243

Reference

Title : Muscarinic receptor subtypes: implications for therapy - Barnes_1993_Agents.Actions.Suppl_43_243
Author(s) : Barnes PJ
Ref : Agents Actions Suppl , 43 :243 , 1993
Abstract :

At least three subtypes of muscarinic receptor have been localised to human airways. M1-receptors facilitate ganglionic transmission and therefore enhance cholinergic reflexes, M2-receptors are localised to post-ganglionic cholinergic nerve terminals and inhibit the release of acetylcholine and M3-receptors on airway smooth muscle mediate constriction and on submucosal glands mediate increased mucus secretion. M3 or mixed M1/M3-receptor antagonists should be preferable to the non-selective anticholinergic drugs in current use, since they would not increase acetylcholine release from cholinergic nerves.

PubMedSearch : Barnes_1993_Agents.Actions.Suppl_43_243
PubMedID: 8368167

Related information

Citations formats

Barnes PJ (1993)
Muscarinic receptor subtypes: implications for therapy
Agents Actions Suppl 43 :243

Barnes PJ (1993)
Agents Actions Suppl 43 :243